• Users Online: 599
  • Print this page
  • Email this page
Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
  Citation statistics : Table of Contents
   2020| January-February  | Volume 31 | Issue 1  
    Online since February 20, 2020

 
 
  Archives   Previous Issue   Next Issue   Most popular articles   Most cited articles
 
Show all abstracts  Show selected abstracts  Export selected to
  Cited Viewed PDF
ORIGINAL ARTICLES
Comparative analysis of robot-assisted, laparoscopic, and open radical prostatectomy regarding lower urinary tract symptoms: A longitudinal study
Shogo Inoue, Tetsutaro Hayashi, Jun Teishima, Akio Matsubara
January-February 2020, 31(1):21-27
DOI:10.4103/UROS.UROS_44_19  
  1 1,827 238
Factors affecting hospital stay in patients aged >65 years who underwent urological intervention: A single-center retrospective study
Elif Bombaci
January-February 2020, 31(1):28-35
DOI:10.4103/UROS.UROS_51_19  
  1 1,753 212
REVIEW ARTICLES
Rational combination with an immunotherapy backbone in genitourinary cancers
Jhe-Cyuan Guo, Chia-Chi Lin
January-February 2020, 31(1):4-7
DOI:10.4103/UROS.UROS_11_19  
  1 2,029 250
CASE REPORT
Prostate tuberculosis: A rare complication of pulmonary tuberculosis with malignant features mimicking prostate cancer
Amogu K Eziyi, Waheed A Oluogun, Kamoru A Adedokun, Ganiyu A Oyeniyi
January-February 2020, 31(1):36-38
DOI:10.4103/UROS.UROS_80_19  
  - 3,391 253
A case with small renal tumor complicated with pulmonary oil embolism after transcatheter arterial embolization
Jui-Shan Hsu, Po-Ming Chow, Po-Chin Liang, Yu-An Chen
January-February 2020, 31(1):39-41
DOI:10.4103/UROS.UROS_84_19  
  - 1,617 227
CME TEST
CME Test

January-February 2020, 31(1):43-44
DOI:10.4103/1879-5226.278880  
  - 1,070 105
EDITORIALS
Immuno-oncology: The frontier in caring urological patients
Stephen Shei-Dei Yang
January-February 2020, 31(1):3-3
DOI:10.4103/UROS.UROS_2_20  
  - 1,374 197
Immune checkpoint therapy: A paradigm shift in combination with curative potential
Tai-Lung Cha
January-February 2020, 31(1):1-2
DOI:10.4103/UROS.UROS_3_20  
  - 1,639 227
LETTER TO THE EDITOR
Adiponectin and proto-oncogene MYC in prostate cancer: How far are we with the evidence?
Vipul D Yagnik
January-February 2020, 31(1):42-42
DOI:10.4103/UROS.UROS_83_19  
  - 1,166 176
ORIGINAL ARTICLES
Prevalence of hand joint symptoms in androgen deprivation therapy among japanese patients with prostate cancer
Shogo Inoue, Tetsutaro Hayashi, Jun Teishima, Akio Matsubara
January-February 2020, 31(1):15-20
DOI:10.4103/UROS.UROS_41_19  
  - 3,163 270
REVIEW ARTICLES
Current and future aspect of immunotherapy for advanced renal cell carcinoma
Fu-Jen Hsueh, Yu Tsai
January-February 2020, 31(1):8-14
DOI:10.4103/UROS.UROS_77_19  
  - 1,904 250